Europe Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030

Europe Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030


The Europe Laboratory-Developed Tests (LDTs) Marketis expected to reach USD 11,396.01 Million by 2030 from USD 5,176.06 million in 2022, growing at a CAGR of 10.4% during the forecast period of 2023 to 2030.

Market Segmentation

Europe Laboratory-Developed Tests (LDTs) Market, By Test Type (Clinical Chemistry and Immunology, Critical Care, Hematology, Molecular Diagnostics, Microbiology, and Other Test), Product Type (Consumables, Analyzers and Instruments, and Accessories), Sample Type (Blood, Urine, Tissue, Cerebrospinal Fluid (CSF), and Others), Therapeutic Area (Infections, Genetic Disorders, Oncology/Cancer, Autoimmune Disease, Urology, Gynecology, and Others), Gender (Male, and Female), Age Group (Geriatrics, Adult, and Pediatric), End Users (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, Academic Institutes, Clinical Research Organizations, Specialty Diagnostic Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors, and Others), Country (Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe) - Industry Trends and Forecast to 2030

Overview of Europe Laboratory-Developed Tests (LDTs) Market Dynamics

Drivers

• Increasing demand for personalized medicines
• Advancements in molecular diagnostics

Restraint

• Stringent quality control and standardization for LDTs
Opportunity

• Increasing demand for precision medicine and targeted therapy

Market Players
Some of the major market players operating in the Europe Laboratory-Developed Tests (LDTs) market are:
• F. Hoffmann-La Roche Ltd
• bioMérieux, Inc.
• Sysmex Corporation
• Biomerica, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• Siemens Medical Solutions USA, Inc.
• Quest Diagnostics Incorporated
• QIAGEN
• Eurofins Scientific
• Biodesix.
• Hologic, Inc.
• Guardant Health
• OPKO Health, Inc.
• BD
• Beckman Coulter, Inc.
• NeoGenomics Laboratories.
• Seegene Inc.
• BGI
• 23andMe, Inc.
• Agendia


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Laboratory-developed Tests (Ldts) Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Test Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's Five Forces Model
5 Industry Insights
6 Number Of Labs
6.1 Number Of Labs In Middle Eastern Countries
6.2 Number Of Labs In Europe
7 Regulations Of The Europe Laboratory-developed Tests (Ldts) Market
7.1 Europe
8 Market Overview
8.1 Drivers
8.1.1 Increasing Demand For Personalized Medicine
8.1.2 Advancements In Molecular Diagnostics
8.1.3 Growing Prevalence Of Chronic Diseases
8.1.4 Increasing Awareness And Acceptance Towards The Assistances Of Ldts
8.2 Restraints
8.2.1 Stringent Quality Control And Standardization For Ldts
8.2.2 Strict Regulatory Guidelines Regarding Ldts
8.3 Opportunities
8.3.1 Increasing Demand For Precision Medicine And Targeted Therapy
8.3.2 Enhanced Healthcare Substructure
8.4 Challenges
8.4.1 Deprived Data Interpretation And Integration
8.4.2 Complex Laboratory Processes
9 Europe Laboratory-developed Tests (Ldts) Market, By Test Type
9.1 Overview
9.2 Clinical Chemistry And Immunology
9.2.1 Glucose
9.2.1.1 Glucose Challenge Test
9.2.1.2 Oral Glucose Tolerance Test (Ogtt)
9.2.2 Prothrombin
9.2.3 Metabolic Panel
9.2.3.1 Basic
9.2.3.2 Comprehensive
9.2.4 Lipid Panel
9.2.5 Liver Panel
9.2.5.1 Alp Test (Alkaline Phosphate)
9.2.5.2 Alt Test (Alkaline Transminase)
9.2.5.3 Ast Test (Aspartate Aminotransferase)
9.2.5.4 Gamma-glutamyl Transferase (Ggt) Test
9.2.6 Thyroid Stimulating Hormone
9.2.7 Urinalysis
9.2.7.1 Red Blood Cell Urine Test
9.2.7.2 Glucose Urine Test
9.2.7.3 Protein Urine Test
9.2.7.4 Urine Ph Level
9.2.7.5 Ketones Urine Test
9.2.7.6 Biliburin Urine Test
9.2.7.7 Urine Specific Gravity Test
9.2.8 Others
9.3 Critical Care
9.3.1 Carboxyhaemoglobin Test
9.3.2 Ph Test
9.3.3 Potassium Test
9.3.4 Sodium Test
9.3.5 Methemoglobin Test
9.3.6 Lactate Test
9.3.7 Others
9.4 Haematology
9.4.1 Complete Blood Count (Cbc)
9.4.1.1 White Blood Cell Count (Wbc)
9.4.1.2 Red Blood Cell Count (Rbc)
9.4.2 Platelet Count
9.4.3 Blood Protein Testing
9.4.4 Others
9.5 Molecular Diagnostic
9.5.1 Sample Type
9.5.1.1 Blood
9.5.1.2 Urine
9.5.1.3 Tissue
9.5.1.4 Cerebrospinal Fluid (Csf)
9.5.1.5 Others
9.5.2 Therapeutic Area
9.5.2.1 Infections
9.5.2.2 Genetic Disorders
9.5.2.3 Oncology/Cancer
9.5.2.4 Autoimmune Disease
9.5.2.5 Urology
9.5.2.6 Gynecology
9.5.2.7 Others
9.5.3 Technology
9.5.3.1 Polymerase Chain Reaction (Pcr)
9.5.3.2 Next-generation Sequencing (Ngs)
9.5.3.3 Fluorescence In Situ Hybridization (Fish)
9.5.3.4 Sanger Sequencing
9.5.3.5 Microarrays
9.5.3.6 Mass Spectrometry
9.5.3.7 Isothermal Amplification
9.5.4 End User
9.5.4.1 Hospital-based Labs
9.5.4.2 Stand-alone Labs
9.5.4.3 Diagnostic Chains
9.5.4.4 Academic Institutes
9.5.4.5 Clinical Research Organizations
9.5.4.6 Specialty Diagnostic Centers
9.5.4.7 Others
9.6 Microbiology
9.6.1 Microscopy
9.6.2 Culture
9.6.3 Antimicrobial Susceptibility Test
9.6.4 Others
9.7 Other Test
9.7.1 Drugs Of Abuse Testing
9.7.2 Hepatitis
9.7.3 Human Immunodeficiency Viruses (Hiv)
9.7.4 Malaria
9.7.5 Tuberculosis
9.7.6 Human Papillomavirus (Hpv)
9.7.7 Others
10 Europe Laboratory-developed Tests (Ldts) Market, By Product Type
10.1 Overview
10.2 Consumables
10.2.1 Panels
10.2.2 Reagent And Kits
10.2.3 Others
10.3 Analyzers And Instruments
10.3.1 Fully-automated Instruments
10.3.2 Semi-automated Instruments
10.3.3 Others
10.4 Accessories
11 Europe Laboratory-developed Tests (Ldts) Market, By Sample Type
11.1 Overview
11.2 Blood
11.3 Urine
11.4 Tissue
11.5 Cerebrospinal Fluid (Csf)
11.6 Others
12 Europe Laboratory-developed Tests (Ldts) Market, By Therapeutic Area
12.1 Overview
12.2 Infections
12.2.1 Methicillin-resistant Staphylococcus Aureus (Mrsa)
12.2.2 Clostridium Difficile
12.2.3 Vancomycin-resistant Enterococci (Vre)
12.2.4 Carbapenem-resistant Bacteria
12.2.5 Flu
12.2.6 Respiratory Syncytial Virus (Rsv)
12.2.7 Candida
12.2.8 Tuberculosis And Drug-resistant Tba
12.2.9 Meningitis
12.2.10 Gastrointestinal Panel Testing
12.2.11 Chlamydia
12.2.12 Gonorrhea
12.2.13 Hiv
12.2.14 Hepatitis B
12.2.15 Hepatitis C
12.2.16 Other Infectious Diseases
12.3 Genetic Disorders
12.3.1 New Born Screening
12.3.2 Predictive And Presymptomatic Testing
12.3.3 Other Genetic Testing
12.4 Oncology/Cancer
12.4.1 Breast Cancer
12.4.2 Prostate Cancer
12.4.3 Colorectal Cancer
12.4.4 Cervical Cancer
12.4.5 Kidney Cancer
12.4.6 Liver Cancer
12.4.7 Blood Cancer
12.4.8 Lung Cancer
12.4.9 Other Cancer
12.5 Autoimmune Disease
12.6 Urology
12.7 Gynecology
12.8 Others
13 Europe Laboratory-developed Tests (Ldts) Market, By Gender
13.1 Overview
13.2 Male
13.3 Female
14 Europe Laboratory-developed Tests (Ldts) Market, By Age Group
14.1 Overview
14.2 Geriatrics
14.3 Adult
14.4 Pediatrics
15 Europe Laboratory-developed Tests (Ldts) Market, By End User
15.1 Overview
15.2 Hospital-based Labs
15.3 Stand –alone Labs
15.4 Diagnostic Chains
15.5 Academic Institutes
15.6 Clinical Research Organistaion
15.7 Specialty Diagnostic
15.8 Others
16 Europe Laboratory-developed Tests (Ldts) Market, By Distribution Channel
16.1 Overview
16.2 Direct Tender
16.3 Retail Sales
16.4 Third Party Distributors
16.5 Others
17 Europe Laboratory-developed Tests (Ldts) Market, By Region
17.1 Europe
17.1.1 Germany
17.1.2 U.K.
17.1.3 France
17.1.4 Italy
17.1.5 Russia
17.1.6 Spain
17.1.7 Netherlands
17.1.8 Switzerland
17.1.9 Belgium
17.1.10 Turkey
17.1.11 Rest Of Europe
18 Europe Laboratory-developed Tests (Ldts) Market, Company Landscape
18.1 Company Share Analysis: Europe
19 Company Profiles
19.1 F. Hoffmann-la Roche Ltd.
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Development
19.2 Biomérieux
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Developments
19.3 Sysmex Corporation
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Company Share Analysis
19.3.4 Product Portfolio
19.3.5 Recent Development
19.4 Biomerica.
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Company Share Analysis
19.4.4 Product Portfolio
19.4.5 Recent Development
List Of Tables
Table 1 Number Of Genetic Testing Laboratories In Eu
Table 2 Europe Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 3 Europe Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 4 Europe Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 5 Europe Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 6 Europe Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 7 Europe Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 8 Europe Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 9 Europe Critical Care In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 10 Europe Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 11 Europe Haematology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)))
Table 13 Europe Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 14 Europe Molecular Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 16 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 17 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 18 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 19 Europe Microbiology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 21 Europe Other Test In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 23 Europe Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 24 Europe Consumables In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 26 Europe Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 27 Europe Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 28 Europe Accessories In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 30 Europe Blood In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 31 Europe Urine In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Tissue In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 33 Europe Cerebrospinal Fluid (Csf) In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 34 Europe Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 35 Europe Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 36 Europe Infections In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 37 Europe Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 38 Europe Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 39 Europe Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 40 Europe Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 41 Europe Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 42 Europe Autoimmune Disease In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 43 Europe Urology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 44 Europe Gynecology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 45 Europe Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 46 Europe Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 47 Europe Male In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 48 Europe Female In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 49 Europe Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 50 Europe Geriatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 51 Europe Adult In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 52 Europe Pediatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 53 Europe Laboratory-developed Tests (Ldts) Market, By End User, 2021-2030 (Usd Million)
Table 54 Europe Hospital-based Lab In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 55 Europe Stand- Alone Labs In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 56 Europe Diagnostic Chains In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 57 Europe Academic Institutes In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 58 Europe Clinical Research Organisation In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 59 Europe Specialty Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 60 Europe Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 61 Europe Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 62 Europe Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 63 Europe Retail Sales In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 64 Europe Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 65 Europe Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 66 Europe Laboratory-developed Tests (Ldts) Market, By Country, 2021-2030 (Usd Million)
Table 67 Europe Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 68 Europe Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 69 Europe Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 70 Europe Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 71 Europe Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 72 Europe Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 73 Europe Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 74 Europe Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 75 Europe Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 76 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 77 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 78 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 79 Europe Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 80 Europe Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 81 Europe Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 82 Europe Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 83 Europe Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 84 Europe Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 85 Europe Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 86 Europe Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 87 Europe Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 88 Europe Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 89 Europe Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 Europe Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 91 Europe Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 92 Europe Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 93 Europe Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 94 Germany Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 95 Germany Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 96 Germany Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 97 Germany Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 98 Germany Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 99 Germany Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 100 Germany Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 101 Germany Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 102 Germany Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 103 Germany Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 104 Germany Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 Germany Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 106 Germany Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 107 Germany Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 108 Germany Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 109 Germany Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 110 Germany Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 111 Germany Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 112 Germany Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 113 Germany Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 114 Germany Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 115 Germany Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 116 Germany Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 117 Germany Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 118 Germany Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 119 Germany Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 120 Germany Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 121 U.K. Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 122 U.K. Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 123 U.K. Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 124 U.K. Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 125 U.K. Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 126 U.K. Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 127 U.K. Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 128 U.K. Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 129 U.K. Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 130 U.K. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 131 U.K. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 132 U.K. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 133 U.K. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 134 U.K. Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 135 U.K. Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 136 U.K. Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 137 U.K. Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 138 U.K. Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 139 U.K. Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 140 U.K. Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 141 U.K. Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 142 U.K. Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 143 U.K. Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 144 U.K. Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 145 U.K. Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 146 U.K. Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 147 U.K. Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 148 France Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 149 France Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Laboratory-developed Tests (Ldts) Market: Segmentation
Figure 2 Europe Laboratory-developed Tests (Ldts) Market: Data Triangulation
Figure 3 Europe Laboratory-developed Tests (Ldts) Market: Droc Analysis
Figure 4 Europe Laboratory-developed Tests (Ldts) Market: Europe Vs Regional Market Analysis
Figure 5 Europe Laboratory-developed Tests (Ldts) Market: Company Research Analysis
Figure 6 Europe Laboratory-developed Tests (Ldts) Market: Interview Demographics
Figure 7 Europe Laboratory-developed Tests (Ldts) Market: Market End User Coverage Grid
Figure 8 Europe Laboratory-developed Tests (Ldts) Market: Dbmr Market Position Grid
Figure 9 Europe Laboratory-developed Tests (Ldts) Market: Vendor Share Analysis
Figure 10 Europe Laboratory-developed Tests (Ldts) Market: Segmentation
Figure 11 Rising Demand For Personalized Medicines And Advancements In Molecular Diagnostics Are Expected To Drive The Growth Of The Europe Laboratory-developed Tests (Ldts) Market From 2023 To 2030
Figure 12 The Clinical Chemistry And Immunology Segment Is Expected To Account For The Largest Share Of The Europe Laboratory-developed Tests (Ldts) Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities And Challenges Of The Europe Laboratory-developed Tests (Ldts) Market
Figure 14 Europe Laboratory-developed Tests (Ldts) Market: By Test Type, 2022
Figure 15 Europe Laboratory-developed Tests (Ldts) Market: By Test Type, 2023-2030 (Usd Million)
Figure 16 Europe Laboratory-developed Tests (Ldts) Market: By Test Type, Cagr (2023-2030)
Figure 17 Europe Laboratory-developed Tests (Ldts) Market: By Test Type, Lifeline Curve
Figure 18 Europe Laboratory-developed Tests (Ldts) Market: By Product Type, 2022
Figure 19 Europe Laboratory-developed Tests (Ldts) Market: By Product Type, 2023-2030 (Usd Million)
Figure 20 Europe Laboratory-developed Tests (Ldts) Market: By Product Type, Cagr (2023-2030)
Figure 21 Europe Laboratory-developed Tests (Ldts) Market: By Product Type, Lifeline Curve
Figure 22 Europe Laboratory-developed Tests (Ldts) Market: By Sample Type, 2022
Figure 23 Europe Laboratory-developed Tests (Ldts) Market: By Sample Type, 2023-2030 (Usd Million)
Figure 24 Europe Laboratory-developed Tests (Ldts) Market: By Sample Type, Cagr (2023-2030)
Figure 25 Europe Laboratory-developed Tests (Ldts) Market: By Sample Type, Lifeline Curve
Figure 26 Europe Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2022
Figure 27 Europe Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2020-2029 (Usd Million)
Figure 28 Europe Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Cagr (2023-2030)
Figure 29 Europe Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Lifeline Curve
Figure 30 Europe Laboratory-developed Tests (Ldts) Market: By Gender, 2022
Figure 31 Europe Laboratory-developed Tests (Ldts) Market: By Gender, 2023-2030 (Usd Million)
Figure 32 Europe Laboratory-developed Tests (Ldts) Market: By Gender, Cagr (2023-2030)
Figure 33 Europe Laboratory-developed Tests (Ldts) Market: By Gender, Lifeline Curve
Figure 34 Europe Laboratory-developed Tests (Ldts) Market: By Age Group, 2022
Figure 35 Europe Laboratory-developed Tests (Ldts) Market: By Age Group, 2023-2030 (Usd Million)
Figure 36 Europe Laboratory-developed Tests (Ldts) Market: By Age Group, Cagr (2023-2030)
Figure 37 Europe Laboratory-developed Tests (Ldts) Market: By Age Group, Lifeline Curve
Figure 38 Europe Laboratory-developed Tests (Ldts) Market: By End User, 2022
Figure 39 Europe Laboratory-developed Tests (Ldts) Market: By End User, 2023-2030 (Usd Million)
Figure 40 Europe Laboratory-developed Tests (Ldts) Market: By End User, Cagr (2023-2030)
Figure 41 Europe Laboratory-developed Tests (Ldts) Market: By End User, Lifeline Curve
Figure 42 Europe Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2022
Figure 43 Europe Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 44 Europe Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Cagr (2023-2030)
Figure 45 Europe Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Lifeline Curve
Figure 46 Europe Laboratory-developed Tests (Ldts) Market: Snapshot (2022)
Figure 47 Europe Laboratory-developed Tests (Ldts) Market: By Country (2022)
Figure 48 Europe Laboratory-developed Tests (Ldts) Market: By Country (2023 & 2030)
Figure 49 Europe Laboratory-developed Tests (Ldts) Market: By Country (2022 & 2030)
Figure 50 Europe Laboratory-developed Tests (Ldts) Market: By Test Type (2023-2030)
Figure 51 Europe Laboratory-developed Tests (Ldts) Market: Company Share 2022 (%) 258

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings